Mr. Joseph Gentile served as the Chief Executive Officer at Stemgent and Key Biologics. Mr. Gentile is a senior executive with a successful record of leadership, with over 30 years of global medical device, diagnostics, and life science industry experience. Prior to joining Stemgent, Joe served as the Vice President and General Manager of both the Discovery Labware and Cell Biology business units of Becton Dickinson (BD) Biosciences, where he led business transformation, growth, and global expansion. Mr. Gentile is also a Board Advisor to Quad Technologies. Joe has a Master's degree in Electrical Engineering and earned his M.B.A. from Boston University. Joe has completed advanced leadership curriculums at MIT and Harvard University.